Expression of clock gene


Journal

BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391

Informations de publication

Date de publication:
08 2020
Historique:
received: 13 04 2020
revised: 19 06 2020
accepted: 02 07 2020
entrez: 21 8 2020
pubmed: 21 8 2020
medline: 22 6 2021
Statut: ppublish

Résumé

We previously reported in ob/ob mice, one of animal models of human type 2 diabetes mellitus (DM2), that (i) acetylation of histone H3 lysine 9 (H3K9) at the promoter region of clock gene The present study was undertaken to evaluate whether such the changes in visceral adipose tissue were detected in patients with DM2. We obtained omental and mesenteric adipose tissue during surgery of lymph node dissection for gastric and colorectal cancers, and investigated these variables in adipose tissue (omental from gastric cancer; 13 non-DM, 12 DM2: mesenteric from colorectal cancer; 12 non-DM, 11 DM2). Acetylation of histone H3K9 at the promoter region of The changes in DBP-PPAR-γ axis observed in mice with diabetes were also detected in patients with DM2. Because adiponectin secretion is reported to be enhanced through the PPAR-γ-related mechanism, this study supports the hypothesis that omental adipose tissue is involved in the mechanism of DM2.

Identifiants

pubmed: 32816832
pii: 8/1/e001465
doi: 10.1136/bmjdrc-2020-001465
pmc: PMC7437886
pii:
doi:

Substances chimiques

DBP protein, human 0
DNA-Binding Proteins 0
PPAR gamma 0
RNA, Messenger 0
Transcription Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Nat Rev Genet. 2008 Oct;9(10):764-75
pubmed: 18802415
Endocrinology. 2012 Jul;153(7):2985-96
pubmed: 22581458
Cell. 1999 Jul 23;98(2):193-205
pubmed: 10428031
Gynecol Endocrinol. 2017 Jan;33(1):75-78
pubmed: 27705028
Metabolism. 2018 Aug;85:32-37
pubmed: 29452178
Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23806-23812
pubmed: 31685618
Diabetes. 2011 May;60(5):1577-81
pubmed: 21411511
Adipocyte. 2015 Apr 01;4(4):273-9
pubmed: 26451283
J Atheroscler Thromb. 2010 Feb;17(1):73-83
pubmed: 20093779
Biochim Biophys Acta. 2012 Nov;1822(11):1796-806
pubmed: 22968146
BMC Genomics. 2010 Apr 21;11:257
pubmed: 20409305
Nat Med. 2001 Aug;7(8):941-6
pubmed: 11479627
Diabetes. 2006 Sep;55(9):2571-8
pubmed: 16936206
Proc Natl Acad Sci U S A. 2004 May 11;101(19):7357-62
pubmed: 15123803
Cell Death Differ. 2006 Apr;13(4):539-50
pubmed: 16167067
Lipids Health Dis. 2016 Nov 23;15(1):204
pubmed: 27881129
J Occup Health. 2005 Mar;47(2):89-95
pubmed: 15824472
Chronobiol Int. 2019 Jul;36(7):955-968
pubmed: 31070057
Cancer Med. 2020 Jun;9(12):4148-4159
pubmed: 32319740
Nutr Metab (Lond). 2004 Nov 05;1(1):12
pubmed: 15530168
EMBO J. 1997 Nov 17;16(22):6762-71
pubmed: 9362490
Bioessays. 1998 Aug;20(8):615-26
pubmed: 9780836
Diabetologia. 2019 Apr;62(4):704-716
pubmed: 30737520
J Endocrinol. 2009 Jan;200(1):3-22
pubmed: 18971218
Nat Genet. 2005 Feb;37(2):187-92
pubmed: 15665827
Obes Rev. 2010 Jan;11(1):11-8
pubmed: 19656312
Mol Cell. 1999 Oct;4(4):585-95
pubmed: 10549290
PLoS One. 2013 Jun 19;8(6):e65583
pubmed: 23840343
Cell Physiol Biochem. 2008;22(5-6):531-8
pubmed: 19088435
BMC Mol Biol. 2004 Oct 09;5:18
pubmed: 15473909
Neurosci Lett. 2018 Feb 14;666:48-57
pubmed: 29273397
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5339-46
pubmed: 14963227
Science. 1998 Jun 5;280(5369):1564-9
pubmed: 9616112
Am J Physiol Regul Integr Comp Physiol. 2015 Mar 1;308(5):R337-50
pubmed: 25519730
J Biol Chem. 2001 Nov 2;276(44):41245-54
pubmed: 11533050
PLoS One. 2014 Nov 03;9(11):e111678
pubmed: 25365257
Chronobiol Int. 2012 Oct;29(8):982-93
pubmed: 22891617

Auteurs

Kentaro Ushijima (K)

Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke, Tochigi, Japan ushijima-kentarou@umin.ac.jp.
Division of Pharmaceutics, Sanyo-Onoda City University, Sanyoonoda, Yamaguchi, Japan.

Chisato Suzuki (C)

Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke, Tochigi, Japan.
Department of Pharmaceutics & Drug Delivery Systems, Tokyo University of Science, Noda, Chiba, Japan.

Hiroko Kitamura (H)

Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke, Tochigi, Japan.

Ken Shimada (K)

Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke, Tochigi, Japan.
Department of Pharmaceutics & Drug Delivery Systems, Tokyo University of Science, Noda, Chiba, Japan.

Hirotoshi Kawata (H)

Division of Human Pathology, Department of Pathology, Jichi Medical University, Shimotsuke, Tochigi, Japan.

Akira Tanaka (A)

Division of Human Pathology, Department of Pathology, Jichi Medical University, Shimotsuke, Tochigi, Japan.

Hisanaga Horie (H)

Division of Gastroenterological Surgery, Department of Surgery, Jichi Medical University, Shimotsuke, Tochigi, Japan.

Yoshinori Hosoya (Y)

Division of Gastroenterological Surgery, Department of Surgery, Jichi Medical University, Shimotsuke, Tochigi, Japan.

Yasushi Imai (Y)

Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke, Tochigi, Japan.

Chikamasa Yamashita (C)

Department of Pharmaceutics & Drug Delivery Systems, Tokyo University of Science, Noda, Chiba, Japan.

Akio Fujimura (A)

Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke, Tochigi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH